You just read:

DelMar Pharmaceuticals Presents Positive Updates on Two Ongoing Clinical Trials with VAL-083 for Treatment of MGMT-unmethylated GBM

News provided by

DelMar Pharmaceuticals, Inc.

Apr 17, 2018, 14:00 ET